
北美封闭系统药物转移装置市场预测至 2027 年 - COVID-19 影响和封闭机制(推转系统、颜色对颜色对准系统、鲁尔锁系统和点击锁定系统)的区域分析)、类型(膜对膜系统和无针系统)、技术(基于隔膜的设备、隔室设备和空气清洁/过滤设备)、组件(小瓶访问设备、注射器安全设备、袋子/管线访问设备和附件)、最终用户(医院和诊所、肿瘤中心等)和地理位置
No. of Pages: 145 | Report Code: TIPRE00014999 | Category: Life Sciences
No. of Pages: 145 | Report Code: TIPRE00014999 | Category: Life Sciences
封闭系统药物转移装置可在药物制备和给药过程中提供针对危险药物或蒸气的保护。它包含能够将危险蒸气过滤出系统的组件。封闭系统药物转移装置在保护医疗保健专业人员免受抗肿瘤药物和其他有害药物的侵害方面发挥着重要作用。
北美封闭系统药物转移装置市场预计将从 2019 年的 1.4359 亿美元增至 2027 年的 6.4878 亿美元。预计 2019 年该市场将以 20.8% 的复合年增长率增长—— 2027年。化疗的日益普及和危险药物监管指南的改进是预计推动北美封闭系统药物转移设备市场增长的主要因素。然而,在预测期内,市场可能会受到严格监管环境和产品安全问题等风险因素的影响。
就闭合机制而言,推转式系统部分在2019年北美闭合系统药物转移装置市场中占据最大份额。就类型而言,膜对膜系统细分市场在2019年北美封闭系统药物转移设备市场中占据最大份额。就技术而言,基于隔膜的设备细分市场在2019年北美封闭系统药物转移设备市场中占据最大份额。从组成部分来看,2019年,小瓶接入装置细分市场占据了北美封闭系统药物转移装置市场的最大份额。从最终用户来看,医院和诊所细分市场占据了北美封闭系统市场的最大份额。 2019年药物转移装置市场。
相关的几个主要一手和二手来源世界卫生组织(WHO)、美国癌症协会(ACS)、美国卫生系统药学协会(ASHP)和美国国家癌症研究所(NCI)等机构发布了北美封闭系统药物转移装置市场报告。 span>
< strong>按技术
;
Strategic insights for North America Closed Systems Drug Transfer Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 143.59 Million |
Market Size by 2027 | US$ 648.78 Million |
Global CAGR (2019 - 2027) | 20.8% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 关闭机制
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Closed Systems Drug Transfer Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Closed Systems Drug Transfer Devices Market
The North America Closed Systems Drug Transfer Devices Market is valued at US$ 143.59 Million in 2019, it is projected to reach US$ 648.78 Million by 2027.
As per our report North America Closed Systems Drug Transfer Devices Market, the market size is valued at US$ 143.59 Million in 2019, projecting it to reach US$ 648.78 Million by 2027. This translates to a CAGR of approximately 20.8% during the forecast period.
The North America Closed Systems Drug Transfer Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Closed Systems Drug Transfer Devices Market report:
The North America Closed Systems Drug Transfer Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Closed Systems Drug Transfer Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Closed Systems Drug Transfer Devices Market value chain can benefit from the information contained in a comprehensive market report.